| 1 |
17118344 | Irofulven induces replication-dependent CHK2 activation related to p53 status. | 2007 Feb 15 |
2 |
| 2 |
17172419 | Fanconi anemia D2 protein confers chemoresistance in response to the anticancer agent, irofulven. | 2006 Dec |
1 |
| 3 |
15269203 | ATM-dependent CHK2 activation induced by anticancer agent, irofulven. | 2004 Sep 17 |
2 |
| 4 |
12855662 | Marked activity of irofulven toward human carcinoma cells: comparison with cisplatin and ecteinascidin. | 2003 Jul |
1 |
| 5 |
10368691 | Cytotoxic effects of MGI 114 are independent of tumor p53 or p21 expression. | 1999 Mar-Apr |
1 |